SmallCaps

Race Oncology raises $29.7m to fund development of lead anti-cancer drug Zantrene

0
ASX:RAC

Watch the video above for detailed insights and analysis.

Video Details

Featured Companies: ASX:RAC
Recorded:

Stay Ahead

Get the latest market insights and analysis delivered to your inbox.